Blog - Page 473 of 5639 - QualityStocks

TuesdayApr 09, 2024 3:35 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Key Data in First-Ever Scientific Presentation of Proprietary HeartBeam AI

HeartBeam(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, is presenting new data at the European Heart Rhythm Association (“EHRA”) Conference. According to the announcement, this is the first scientific presentation on the company’s deep learning algorithm: HeartBeam AI. The data demonstrates that applying the company’s artificial intelligence (“AI”) algorithms to vectorcardiography (“VCG”) showed considerably improved performance in the detection of atrial flutter over single-lead electrocardiograms (“ECGs”) and similar performance to 12-lead ECGs, the standard for diagnosing atrial flutter. The company noted that the data indicates an opportunity for a VCG-based algorithm…

TuesdayApr 09, 2024 3:08 pm

QualityStocksNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Featured in Bell2Bell Podcast

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Thomas Ullrich, CEO of Aston Bay, joined the program to provide an introduction to Aston Bay and its business model. “Overall, Aston Bay is in the business of adding value through discovery of high-grade critical metals and precious metals deposits,” Ullrich said in the interview. “We’re an exploration stage company. Really…

TuesdayApr 09, 2024 10:30 am

Bebuzee Inc. (BBUZ) Is ‘One to Watch’

Bebuzee in November 2023 announced completion of its superapp, which combines multiple digital services into a single, user-friendly platform for the U.S. and European markets In September 2022, the company filed with the SEC for a Regulation A registration exempt public offering of up to $75 million of its common shares The company in April 2022 announced a private placement offering of up to $10 million of its common shares Bebuzee (OTC: BBUZ), formerly Engage Mobility Inc., is a social platform and streaming service focused on development and deployment of America’s first superapp. The superapp will allow members to watch…

TuesdayApr 09, 2024 9:45 am

SenesTech Inc. (NASDAQ: SNES) Inks Distribution Agreement with Wilco Distributors for Evolve(TM) Soft Bait

SenesTech, a company that offers fertility control products for rodent pests, launched Evolve(TM) Soft Bait in October 2023, and has so far inked multiple distribution agreements as part of its multi-prong go-to-market strategy for the product The company recently announced it had signed a distribution agreement with Wilco Distributors Inc., a Glendale, Arizona-based distributor of pest management baits and tools to the rodent pest management market In addition to Evolve, SenesTech also offers ContraPest(R), a highly palatable professional-grade contraceptive liquid formulation for both male and female rats Evolve and ContraPest are positioned as effective non-lethal alternatives to registered rodenticides that…

TuesdayApr 09, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) has Emerged as a Leader in the Neurodegenerative Field Utilizing a Novel Nanotherapeutic Drug

Clinical trials of Clene’s lead candidate CNM-Au8(R) have shown notable success in crossing the blood-brain barrier and enhancing the brain's bioenergetic metabolites, essentially "reversing the clock" on what would be considered healthy aging CNM-Au8 has shown promise in clinical trials for both ALS and MS, including improvements in survival rates and clinical function Clene was recently featured in an interview of CEO Rob Etherington on ‘First in Human’ podcast In a significant advancement for the treatment of neurodegenerative diseases, Clene (NASDAQ: CLNN) has innovated CNM-Au8, an oral nanotherapeutic designed to revitalize the brain's mitochondrial function. The potential of this drug…

MondayApr 08, 2024 3:33 pm

QualityStocksNewsBreaks – DeFi Technologies Inc. (CBOE CA: DEFI) (OTCQB: DEFTF) Subsidiary to Introduce 15 New ETP Products in 2024; 30 in 2025

DeFi Technologies (CBOE CA: DEFI) (GR: R9B) (OTCQB: DEFTF), a FinTech company establishing itself as the first and only publicly traded company that bridges the gap between traditional capital markets, Web3 and DeFi, today announced a significant stride in its mission to enhance global accessibility to regulated digital assets as it grows globally. Valour Inc., a leading issuer of exchange traded products ("ETPs") that provide simplified access to digital assets, aims to expand its assets under management ("AUM") by launching 15 new ETP products this year, in addition to the 17 already listed in Europe. Next year, the subsidiary plans…

MondayApr 08, 2024 3:25 pm

QualityStocksNewsBreaks – Upstream Announces Upstream Accelerate, New Program That Empowers Athletes to Raise Sponsorship

Upstream, the revolutionary retail trading app for stocks and NFTs powered by Horizon Fintex and MERJ Exchange Limited, has introduced an exciting new program designed to empower athletes to raise sponsorship through the sale of collectibles. The program — Upstream Accelerate — provides a way for athletes to use their email and social media channels to encourage and allow fans to sponsor them, while Upstream handles the collectible media as well as setup and creation fees. The Upstream launched the program during its “Upstream Up Close” series on Twitter Spaces, which features 10–15 minute discussions on the world of digital collectibles, Web3…

MondayApr 08, 2024 3:14 pm

QualityStocksNewsBreaks – Authentic Holdings Inc.’s (AHRO) Subsidiary Partners to Launch iDreamCTV: A Cutting-Edge Streaming Platform

Maybacks Global Entertainment, a subsidiary of Authentic Holdings (OTC: AHRO), today announced its partnership with WiseDV, a leading streaming and broadcast technology provider. Under the collaboration, they unveil and officially launch iDreamCTV, a next-generation over-the-top (“OTT”) platform set to revolutionize the streaming experience. “Working with WiseDV on this one-of-a-kind and innovative app has been seamless. Their expertise and constant communication have enabled us to provide users with features typically reserved for subscription-based services,” said Chris Giordano, president and chairman of Authentic Holdings. “We now make our user experience second to none in terms of its functionality and its user interface.…

MondayApr 08, 2024 2:58 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Streamlines Operations to Focus on Commercial Segment

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that the company has initiated significant cost reduction and consolidation measures, aligning budget to current conditions. Actions are expected to drive an estimated $170 million reduction in Mullen’s operating and investing cash flow expenses over the next 12 months when compared to operating and investing cash flows for the 12 months ended Sept. 30, 2023. The company is making these changes to refine business operations and better align focus on the commercial EV segment that has opportunity to drive near term revenue for Mullen, including projected April sales…

MondayApr 08, 2024 2:45 pm

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), Scinai Bioservices Enter MSA with Ayana Pharma

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products, through its contract development and manufacturing organization (“CDMO”) business unit, Scinai Bioservices, has signed a five-year Master Service Agreement (“MSA”) with Ayana Pharma Ltd. As outlined by the MSA, Scinai will provide drug-development and cGMP manufacturing services to Ayana; the agreement is forecast to bring in at least $1.8 million in revenues for Scinai over the next five years. Ayana officials noted that the company had done an extensive search looking for a CDMO and was “attracted” to Scinai’s experience in biopharmaceutical drug development and manufacturing for…

Site Search

Company Search